Abstract
Osteoclasts are crucial in the events leading to bone metastasis of lung cancer. Interleukin-17A (IL-17A) affects osteogenesis by regulating the survival of osteoclast precursors (OCPs) and is enriched in lung cancer cells. However, how factors derived from tumor cells that metastasize to bone affect osteoclastogenesis remains poorly understood. We examined whether IL-17A derived from lung cancer cells affects osteoclast differentiation by regulating OCP apoptosis. IL-17A expression was inhibited in A549 non-small cell lung cancer cells using RNA interference. Compared with conditioned medium (CM) from A549 cells (A549-CM), CM from IL-17A-deficient A549 cells (A549-si-CM) suppressed osteoclastogenesis. The mRNA expression of osteoclast-specific genes was downregulated following A549-si-CM treatment. Furthermore, A549-si-CM promoted osteoclast precursor apoptosis at an early stage of osteoclastogenesis, which was related to the promotion of caspase-3 expression by A549-si-CM during osteoclast differentiation. In vivo experiments also showed that inhibition of IL-17A expression in A549 cells reduced osteoclast activation and bone tissue destruction. Collectively, our results indicate that IL-17A deficiency inhibits lung cancer-induced osteoclast differentiation by promoting apoptosis of osteoclast precursors in the early stage of osteoclast formation and that IL-17A is a potential therapeutic target for cancer-associated bone resorption in patients with lung cancer.
Funder
National Natural Science Foundation of China
Natural Science Foundation of Guangxi Province
Publisher
Public Library of Science (PLoS)
Reference32 articles.
1. Lung cancer survival among never smokers;A Casal-Mourino;Cancer letters,2019
2. Non-Small Cell Lung Cancer, Version 6.2015;DS Ettinger;J Natl Compr Canc Netw,2015
3. Sociodemographic disparities in the management of advanced lung cancer: a narrative review;JN Stein;Journal of thoracic disease,2021
4. The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases;S Rinaldi;Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer,2019
5. Bone metastasis after stage IIIA non-small cell lung cancer: risks and prognosis;CM Bessa;J Bras Pneumol,2022
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献